These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 593965)

  • 1. Binding of sulfonylurea derivatives to bovine serum albumin: part II. The relationship of binding to albumin, chemical structure, and hypoglycemic activity of sulfonamide derivatives of 2-pyrazoline-1-carboxamide.
    Wójcikowski C; Brzozowski Z; Chorosiński A
    Pol J Pharmacol Pharm; 1977; 29(5):477-83. PubMed ID: 593965
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Influence of some salicylates and sulfonamides on binding by albumin of SPC-703 and tolbutamide.
    Wójcikowski C; Szlabowicz D
    Pol J Pharmacol Pharm; 1976; 28(2):129-35. PubMed ID: 945561
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Binding of sulfonylurea derivatives to bovine serum albumin: part I. Binding of SPC--703, tolbutamide, glibornuride and glipizide.
    Wójcikowski C; Szlabowicz D
    Pol J Pharmacol Pharm; 1977; 29(5):469-75. PubMed ID: 22846
    [No Abstract]   [Full Text] [Related]  

  • 4. [New compounds and reactions of sulfonamides with amines. XIV. Hypoglycemic properties of some derivatives of N-(benzenosulfonyl)-delta-2-pyrazoline-1-carboxamide].
    Brzozowski Z; Angielski S; Wójcikowski C
    Acta Pol Pharm; 1974; 31(5):601-6. PubMed ID: 4447012
    [No Abstract]   [Full Text] [Related]  

  • 5. [Relationship between hypoglycemic activity and binding ability with bovine serum albumin of sulfonylurea related compounds (author's transl)].
    Yoshitomi H; Nakayama T; Goto S
    Yakugaku Zasshi; 1981 Oct; 101(10):926-31. PubMed ID: 7338790
    [No Abstract]   [Full Text] [Related]  

  • 6. [New compounds and reactions of sulfonamides with amines. XV. Synthesis and hypoglycemic activity of some derivatives of N-(benzenesulfonyl)-3,5-diethyl-5-methyl-2-pyrazoline-1-carbonamide].
    Brzozowski Z; Dekarz B; Angielski S; Wójcikowski C
    Acta Pol Pharm; 1976; 33(3):301-5. PubMed ID: 941694
    [No Abstract]   [Full Text] [Related]  

  • 7. [New compounds and reactions of sulfonamides with amines. XII. Synthesis of some derivatives of N-(benzenesulfonyl)-delta 2-pyrazoline-1-carboxamide].
    Brzozowski Z
    Acta Pol Pharm; 1974; 31(3):293-9. PubMed ID: 4849239
    [No Abstract]   [Full Text] [Related]  

  • 8. [Compounds and reactions of sulfonamides with amines. 13. Synthesis of some derivatives of N-(benzenesulfonyl)-delta 2-pyrazoline-1-carboxamide].
    Brzozowski Z
    Acta Pol Pharm; 1974; 31(3):301-4. PubMed ID: 4848358
    [No Abstract]   [Full Text] [Related]  

  • 9. Biotransformation of a new hypoglycemic agent, N-(p-toluenesulfonyl)-5-methyl-2-pyrazoline-1-carbonamide (SPC-703) in humans and rats.
    Jakubowski Z; Angielski S
    Pol J Pharmacol Pharm; 1980; 32(1):37-46. PubMed ID: 7454610
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Derivatives of pyrazole-l-carboxylic acid. VII. Synthesis and hypoglycemic properties of various N-(4-[2-(alkyl-2-pyrazoline-1-carbonamido)-ethyl]-benzenesulfonyl)-N'-cyclohexylurea].
    Brzozowski Z; Magiełka S; Wójcikowski C
    Acta Pol Pharm; 1983; 40(2):134-8. PubMed ID: 6659996
    [No Abstract]   [Full Text] [Related]  

  • 11. Pharmacokinetics of a new hypoglycemic agent SPC-703.
    Jakubowski Z; Angielski S
    Pol J Pharmacol Pharm; 1980; 32(2):165-72. PubMed ID: 7454622
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Spectroscopic studies on binding of 1-phenyl-3-(coumarin-6-yl)sulfonylurea to bovine serum albumin.
    Liu XH; Xi PX; Chen FJ; Xu ZH; Zeng ZZ
    J Photochem Photobiol B; 2008 Aug; 92(2):98-102. PubMed ID: 18571426
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The influence of SPC-703 on blood pressure in rabbits and rats and on isolated heart of guinea pigs.
    Matuszek M; Gagało I; Hać E
    Pol J Pharmacol Pharm; 1979; 31(5):455-9. PubMed ID: 547276
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Drug interactions of gliclazide and other sulfonylureas in protein binding in vitro and in hypoglycemic effect in rats.
    Fujii T; Nakamura K; Furukawa H; Watanabe M; Kuwashima J; Miyazaki H; Kawashima K; Kuzuya T
    Arzneimittelforschung; 1983; 33(11):1535-7. PubMed ID: 6686448
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interactions of sulfonylureas with plasma proteins.
    Hsu PL; Ma JK; Luzzi LA
    J Pharm Sci; 1974 Apr; 63(4):570-3. PubMed ID: 4208196
    [No Abstract]   [Full Text] [Related]  

  • 16. Binding of sulfonylurea-related compounds with bovine serum albumin.
    Goto S; Yoshitomi H; Nakase M
    Chem Pharm Bull (Tokyo); 1978 Feb; 26(2):472-80. PubMed ID: 639174
    [No Abstract]   [Full Text] [Related]  

  • 17. Stereospecific plasma binding of gliflumide, a new antidiabetic drug.
    Schillinger E; Ehrenberg I; Lübke K
    Biochem Pharmacol; 1978 Mar; 27(5):651-3. PubMed ID: 566105
    [No Abstract]   [Full Text] [Related]  

  • 18. Synthesis and in vitro antitumor evaluation of some indeno[1,2-c]pyrazol(in)es substituted with sulfonamide, sulfonylurea(-thiourea) pharmacophores, and some derived thiazole ring systems.
    Rostom SA
    Bioorg Med Chem; 2006 Oct; 14(19):6475-85. PubMed ID: 16806944
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of nitric oxide on the ligand-binding activity of albumin.
    Kashiba-Iwatsuki M; Miyamoto M; Inoue M
    Arch Biochem Biophys; 1997 Sep; 345(2):237-42. PubMed ID: 9308895
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The pharmacological blockade of protein glycosylation in diabetes mellitus using sulfonylurea derivatives and biguanides].
    Lebedeva EA
    Eksp Klin Farmakol; 1996; 59(5):40-2. PubMed ID: 9026209
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.